References
- Revicki D A, Rothman M, Luce B. Health-related Quality of Life assessment and the pharmaceutical industry. PharmacoEconomics 1992; 1: 394–408
- Scheman C R. Patient information and education about drugs: the FDA perspective. Drug Inf J 1993; 27: 1133–6
- Coons S J, Kaplan R M. Issues in health policy. Assessing health-related Quality of Life: application to drug therapy. Clin Ther 1992; 14: 850–8
- Johnson J R, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985; 69: 1155–9
- Wenger N K. Assessment of Quality of Life: a medical imperative. Cardiovasc Drugs Ther 1988; 1: 553–8
- Smith N D. Quality of Life studies from the perspective of an FDA reviewing statistician. Drug Inf J 1993; 27: 617–23
- Morris L A. A marketing perspective. Quality of Life assessments in clinical trials, B Spüker. Raven Press, New York 1990; 171–82
- Anon. Quality of Life ad claims should not be based on openlabel ‘seeding’ studies; FDA has continuing ‘concerns’ about Quality of Life claims in general. FDC Reports 1991; 53: 15–6
- Morris L A. New FDA policy initiatives: pharmacoeconomics, cost effectiveness, Quality of Life. DIA Newsletter 1995; 31: 61–2
- Committee to develop standards for educational and psychological testing. Standards for educational and psychological testing. American Psychological Association, Washington, D.C. 1985
- Mac Keigan L D, Pathak D S. Overview of health-related Quality of Life measures. Am J Hosp Pharm 1992; 49: 2236–45
- Fletcher A E. Measurement of Quality of Life in clinical trials of therapy. Rec Res Canc Res 1988; 111: 216–30
- Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of Life measures in health care. I: Applications and issues in assessment. BMJ 1992; 305: 1074–7
- Aaronson N K. Quality of Life assessment in clinical trials: methodologic issues. Contr Clin Trials 1989; 10: 195S–208S
- Aaronson N K. Assessing the Quality of Life of patients in cancer clinical trials: common problems and common sense solutions. Eur J Cancer 1992; 28A: 1304–7
- Gore S, Fletcher A, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of Life measures in health care. II: Design, analysis, and interpretation. BMJ 1992; 305: 1145–8
- Cella D F, Wiklund I, Shumaker S A, Aaronson N K. Integrating health-related Quality of Life into cross-national clinical trials. Quality of Life Res 1993; 2: 433–40